share_log
Benzinga ·  Jun 18 10:57
Biodexa Pharmaceuticals Has Been Granted U.S. Patent Number 12,011,445 Titled "Prevention Of Pancreatic Cell Degeneration (For The Treatment Of Type I Diabetes)". This Patent Is Licensed From Melior Pharmaceuticals
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment